#PassageBio - Twitter Hashtag

over 3 years ago

Mark Forman, MD, PhD, Chief Medical Officer at Passage Bio, gives an overview of frontotemporal dementia (FTD) with granulin (GRN) mutations. @Passage_Bio @FTDPIA https://t.co/9czAcJL39Q #globalphase1/2upliFT-Dclinicaltrial #GRN #FTD #raredisease #MarkForman #PassageBio

0

2

0

98

CheckRare

@CheckRare

over 3 years ago

Mark Forman, MD, PhD, Chief Medical Officer at Passage Bio, gives an overview of frontotemporal dementia (FTD) with granulin (GRN) mutations. @Passage_Bio @FTDPIA https://t.co/9czAcJLAZo #globalphase1/2upliFT-Dclinicaltrial #GRN #FTD #raredisease #MarkForman #PassageBio

0

2

0

116

Passage Bio @Passage_Bio

over 3 years ago

Competition was in the air this week at our SOUPer Bowl Chili Cookoff! Our employees from Philadelphia and Princeton had a blast taking part in the challenge with their creative concoctions. Well done to all participants and the winners—cheers to you! #TogetherTuesday #PassageBio

Passage_Bio's tweet photo. Competition was in the air this week at our SOUPer Bowl Chili Cookoff! Our employees from Philadelphia and Princeton had a blast taking part in the challenge with their creative concoctions. Well done to all participants and the winners—cheers to you! #TogetherTuesday #PassageBio https://t.co/MEgCocFJEl

0

1

0

137

CheckRare

@CheckRare

over 3 years ago

Mark Forman, MD, PhD, Chief Medical Officer at Passage Bio, gives an overview of frontotemporal dementia (FTD) with granulin (GRN) mutations. @Passage_Bio @FTDPIA https://t.co/9czAcJL39Q #globalphase1/2upliFT-Dclinicaltrial #GRN #FTD #raredisease #MarkForman #PassageBio

0

2

0

74

Passage Bio @Passage_Bio

over 3 years ago

We’re excited to be ushering in the new year and will continue our work progressing toward a future where #genetherapy offers treatment options for those suffering from #CNS disorders. We hope 2023 will be a milestone year for #PassageBio and #Patients: https://t.co/9e1WwfVcyU

0

3

0

231

CheckRare

@CheckRare

over 3 years ago

Mark Forman, MD, PhD, Chief Medical Officer at Passage Bio, gives an overview of frontotemporal dementia (FTD) with granulin (GRN) mutations. @Passage_Bio @FTDPIA https://t.co/9czAcJL39Q #globalphase1/2upliFT-Dclinicaltrial #GRN #FTD #raredisease #MarkForman #PassageBio

0

2

0

213

CheckRare

@CheckRare

over 3 years ago

Mark Forman, MD, PhD, Chief Medical Officer at Passage Bio, gives an overview of frontotemporal dementia (FTD) with granulin (GRN) mutations. @Passage_Bio @FTDPIA https://t.co/9czAcJL39Q #globalphase1/2upliFT-Dclinicaltrial #GRN #FTD #raredisease #MarkForman #PassageBio

0

1

0

CureViolet @3rdCallProd

about 5 years ago

Thank you @LongBeachPost for this amazing article supporting Baby Violet’s fight against GM1 Gangliosidosis! https://t.co/U6pDb6BgjA #gangliosidosis #gm1 #curegm1 #raredisease #sio #passagebio #lysogene #genetherapy

0

2

0

KrabbeConnect @KrabbeConnect

about 5 years ago

Thank you to our current committed sponsors for your help to #curekrabbe: #neurogene, #passagebio, #forgebiologics, #tloaf, #upmc, #wingsinsurance, #P4KR, #caseyfinancialservices, #traditioncapitolbank Want to join this sponsors, email us at [email protected].

0

4

3

0

Brad A. Molotsky @bmolotsky

over 6 years ago

#GeneTherapy - #Philadelphia continues to be one of the key cities in the US for gene therapy. #PassageBIO files for $125M IPO. Congrats. Office and lab space continue to be built and planned to accommodate this type of use in Philly. https://t.co/EKk5XHPV9n via @PHLBizJournal

0

3

0